MoonLake Reports Strong One-Year Phase 3 Results f...
Category : Clinical Trial Update 24 June 2026MoonLake Immunotherapeutics has announced positive Week 52 results from its Phase 3 VELA-1 and VELA-...
Clinical Trial Update
CureGene Doses First Patient in US Pivotal Trial o...
Category : Clinical Trial Update 24 June 2026CureGene Pharmaceutical has announced that the first participant has been successfully dosed in the...
Agomab Unveils Phase 2b Study Design for Ontuniser...
Category : Clinical Trial Update 24 June 2026Agomab Therapeutics has announced the design of its upcoming Phase 2b NOV-ERA clinical trial for ont...
uniQure Reports Early Clinical Data for Gene Thera...
Category : Clinical Trial Update 23 June 2026uniQure NV has announced initial six-month follow-up results from the first patient group enrolled i...
Ananda Pharma Completes Phase 1 Study of MRX1 Cann...
Category : Clinical Trial Update 19 June 2026Ananda Pharma Reports Positive Phase 1 Results for MRX1 UK-based Ananda Pharma has announced the...
Latest Newsletter Post
-
Agomab Unveils Phase 2b Study Desig..
24 June 2026
-
CureGene Doses First Patient in US..
24 June 2026
-
MoonLake Reports Strong One-Year Ph..
24 June 2026
-
uniQure Reports Early Clinical Data..
23 June 2026
-
AbbVie to Acquire Apogee Therapeuti..
23 June 2026
